Serum N-Glycans: A New Diagnostic Biomarker for Light Chain Multiple Myeloma

The aim of this study was to evaluate the diagnostic and differential diagnostic power of serum N-glycans for light chain multiple myeloma (LCMM). A total of 167 cases of subjects, including 42 LCMM, 42 IgG myeloma, 41 IgA myeloma, and 42 healthy controls were recruited in this study. DNA sequencer-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jie, Fang, Meng, Zhao, Yun-Peng, Yi, Chang-Hong, Ji, Jun, Cheng, Cheng, Wang, Meng-Meng, Gu, Xing, Sun, Quan-Sheng, Chen, Xiao-Ling, Gao, Chun-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468189/
https://www.ncbi.nlm.nih.gov/pubmed/26075387
http://dx.doi.org/10.1371/journal.pone.0127022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468189/
https://www.ncbi.nlm.nih.gov/pubmed/26075387
http://dx.doi.org/10.1371/journal.pone.0127022

Ejemplares similares